Literature DB >> 6164098

Nonhemolytic, noninfectious transfusion reactions.

J C Barton.   

Abstract

The delivery of optimal transfusion therapy requires that the physician first have a thorough understanding of his patient's disease and prior transfusion history. Sometimes the need for blood product administration is more apparent than real. In the selection of necessary therapy, particular blood components, their volumes, and the timing of their administration should be carefully planned. The transfusion of whole blood, particularly as single-unit transfusions, is rarely indicated. Often forgotten, autotransfusion represents a means whereby many subjects who have repeated, unusual, or severe reactions may receive safe treatment. An appreciation of the frequency and manifestations of transfusion-related problems permits effective treatment of ongoing reactions. The prophylactic measures which should be taken against future reactions in most patients are specific, and are the responsibility of the clinician, based upon his bedside observations and laboratory studies. Problems should be discussed with either a hematologist, pathologist, or blood banking expert without hesitation. These guidelines help conserve a precious resource and assure that safe, effective, and economical transfusion therapy is available for all patients in need.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164098

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  9 in total

1.  Maxiprep genomic DNA extractions for molecular epidemiology studies and biorepositories.

Authors:  Christian Alberto Garcia-Sepulveda; Enrique Carrillo-Acuña; Sandra Elizabeth Guerra-Palomares; Montserrat Barriga-Moreno
Journal:  Mol Biol Rep       Date:  2009-07-17       Impact factor: 2.316

2.  Autologous blood predeposit for elective surgery: an Italian experience.

Authors:  P Rebulla; A M Giovanetti; F Mercuriali; G Sirchia
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

3.  The development of anti-HLA antibodies in multiply transfused preterm infants.

Authors:  A R Bedford Russell; R P Rivers; N Davey
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

Review 4.  Supportive therapy in management of leukemias.

Authors:  V P Choudhry; N Desai
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

5.  Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction.

Authors:  B E Ley; C J Linton; D M Bennett; H Jalal; A B Foot; M R Millar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

6.  Transfusion and bleeding in coronary artery bypass grafting: an on-pump versus off-pump comparison.

Authors:  Kieron C Potger; Darryl McMillan; Joanne Southwell; Terry Connolly; Kate Kingsford Smith; Mark Ambrose
Journal:  J Extra Corpor Technol       Date:  2007-03

7.  Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components.

Authors:  S Imoto; N Araki; E Shimada; K Saigo; K Nishimura; Y Nose; Y Bouike; M Hashimoto; H Mito; H Okazaki
Journal:  Transfus Med       Date:  2007-12       Impact factor: 2.019

Review 8.  Hematologic and oncologic complications in the critically ill child.

Authors:  S McIntosh
Journal:  Yale J Biol Med       Date:  1984 Mar-Apr

9.  Clinical approach to fever in the neurosurgical intensive care unit: Focus on drug fever.

Authors:  Burke A Cunha
Journal:  Surg Neurol Int       Date:  2013-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.